Researcher doggedly pursues new treatments for traumatic brain injury patients in coma

April 7, 2011 in Medical research

We've all watched it unfold on soap operas, medical dramas and films: A patient falls into a coma, and loved ones at the bedside try to peel away the veil by talking or reading aloud. Some of us have done it ourselves, desperately hoping for any hint of wakening or awareness.

For Theresa Louise-Bender Pape, who studies patients with traumatic brain injury in various stages of coma and recovery, the "it can't hurt" reasoning just isn't good enough. She needs evidence. She wants answers.

Pape thinks and talks fast, and her hectic schedule keeps her on the go. The speech pathologist and neuroscientist travels regularly between Washington, D.C., because she works for the Department of Veterans Affairs, and Illinois, where she is based at the Hines VA hospital and is on faculty at Northwestern University's Feinberg School of Medicine. Her nonstop pace makes it seem as if she's trying to make up for lost time, and, in a way, she is – but not for herself.

Pape has made it her life's work to develop therapies that will, essentially, jump-start the lives of patients with traumatic brain injury. Her study subjects are veterans, warriors and civilians who are in states of disordered consciousness (vegetative and/or minimally conscious), people who she says often fall silently through the cracks of the medical system, sometimes going from an acute-care hospital to a nursing home with no rehabilitation regimen at all. Her multiple appointments and affiliations speak to the wide net she has cast as she pursues treatments that may one day engage key parts of the brain that control and maintain arousal and alertness, the parts that really make us come alive.

"I'm not someone who can sit still," she says. "I'm going to be most engaged in my life the more challenges you give me. It's just the nature of who I am."

But what really fuels Pape's afterburners is the hope that, the next time she sees one of her patients, he or she will be sitting up and talking to her, which has, indeed, happened before. You can get hooked on a payoff like that.

At 10:30 a.m. Wednesday in Room 101 of the Walter E. Washington Convention Center in D.C., Pape will describe her work during a 20-minute talk at the annual meeting of the American Association of Anatomists, which is being held in conjunction with the Experimental Biology 2011 conference. Her symposium will include a series of talks about .

Pape's talk will cover the unique challenges and the triumphs her team has experienced over the past few years while conducting two innovative clinical trials: one that pipes familiar voices into the ears of unconscious patients and one that sends magnetic pulses into the neuronal centers of the brain. Both projects are funded, in part, by the U.S. Department of Veterans Affairs, Rehabilitation Research and Developmental Service.

One of the studies is a double-blind, randomized trial in which family members and loved ones of the patients play very important roles. First, baseline tests are conducted using functional MRI to see which parts of a patient's brain are activated by familiar voices and unfamiliar voices telling short stories or what Pape admits are "rather lame jokes" and then nonverbal sounds, such as bells and whistles.

For the next six weeks, participants listen to digital recordings of their friends and relatives telling stories of escapades in which they and the patient participated. The therapy consists of four, 10-minute listening sessions each day, seven days a week for six weeks.

"We've had sisters tell stories from childhood like, 'Remember when we had breakfast together and mom would make eggs and we'd hide them under our plates?'" Pape explains. "If it's about a ski trip, we want adjectives so that the patient can envision motion and flying down the hill."

The effect of the familiar voice intervention is determined with bedside tests of neurobehavioral functioning as well as fMRI and diffusion tensor imaging (DTI).

"Neurobehavioral functioning is a measure that reflects the level of each patient's neural functioning from a behavioral perspective. The neurobehavioral or bedside measures will determine if neural functioning, measured behaviorally, is better after receiving the familiar voice intervention," Pape says. "Both fMRI and DTI will be used to see if the mediators of neurobehavioral functioning can be identified."

Pape has worked with 13 subjects so far, most of them male and about one-third of them veterans or warriors, and she intends to enroll up to 45 participants. About one-third of the patients are being cared for in nursing homes.

"I wanted to give families, therapists and physicians a treatment that held promise, that could easily be done at the bedside and be easily administered and relatively cheap to do," Pape says. "It would be nice if everybody, regardless of if they're in a nursing home or not, was getting to listen to familiar stories."

In the second trial, Pape works with hospitalized patients who get around-the-clock care. She's investigating the safety and efficacy of transcranial magnetic stimulation (TMS). That's a fancy way of saying that she wants to know if it's safe and potentially helpful to place a special figure-of-eight-shaped coil on a patient's scalp to transfer magnetic pulses, originating from a generator, into brain tissue, subsequently making neurons fire. Pape says she hopes that repeated stimulation will make the neurons "talk to each other."

"Over time, I would love it if one neuron in the front relayed information to other neurons, ultimately transmitting this information to the brain stem and thereby reactivating those systems that maintain our arousal and alertness and then kicking back up to the thalamus and re-engaging our cortices," she says.

So far, two patients have completed the noninvasive TMS therapy, which consists of 30 treatments. The first patient, over time, improved from a vegetative state to a minimally conscious state. The second improved from a vegetative state to a conscious state.

"At the end of 30 treatments, the second patient was minimally conscious. He wasn't fully conscious yet, but he hadn't received any rehab at all," Pape says. So she helped arrange for him to get rehabilitative therapy at his nursing home, and he started receiving new medications. "He went six weeks without our experimental treatment, and, when we readmitted him, he was sitting up and he started talking to us!"

"Watching our patient suddenly start talking was really cool," she adds.

After Pape's talk, three presentations will be given by Peter Bergold of the State University of New York-Downstate Medical Center, Walter High of the University of Kentucky and the Lexington VA Medical Center, and Dorothy Kozlowski of DePaul University.

Provided by Federation of American Societies for Experimental Biology search and more info website

not rated yet  

Rank not rated yet
Related Stories
Relevant PhysicsForums posts
  • A couple of questions about schizophrenia
    createdMay 17, 2012
  • Paralyzed woman uses thoughts to move robotic arm
    createdMay 17, 2012
  • Coffee Decreases Risk of Death
    createdMay 17, 2012
  • Understanding the mechanisms of disease .
    createdMay 14, 2012
  • Short burst of hypersensitivity disorder?
    createdMay 13, 2012
  • Copper aspirinate
    createdMay 12, 2012
  • More from Physics Forums - Medical Sciences

More news stories

Hitting parasites where they hurt: New research shows promise in the fight against Toxoplasmosis

Toxoplasmosis, a disease caused by the parasite Toxoplasma gondii, is one of the most common parasitic infections in the world. In the U.S. it is estimated that more than 22 percent of the population 12 years and older have ...

Medical research created 2 hours ago | popularity not rated yet | comments 0

Drug found for Entamoeba histolytica parasite that is major cause of death worldwide

Research by a collaborative group of scientists from UC San Diego School of Medicine, UC San Francisco and Wake Forest School of Medicine has led to identification of an existing drug that is effective against ...

Medical research created 19 hours ago | popularity 5 / 5 (1) | comments 0 | with audio podcast

When you eat matters: Study offers drug-free intervention to prevent obesity, diabetes

It turns out that when we eat may be as important as what we eat. Scientists at the Salk Institute for Biological Studies have found that regular eating times and extending the daily fasting period may override ...

Medical research created May 17, 2012 | popularity 5 / 5 (15) | comments 7 | with audio podcast

Pain relief through distraction -- it's not all in your head

Mental distractions make pain easier to take, and those pain-relieving effects aren't just in your head, according to a report published online on May 17 in Current Biology.

Medical research created May 17, 2012 | popularity 5 / 5 (2) | comments 2 | with audio podcast

Study identifies a hormone that may help hibernating bears avoid bone loss

A hormone that plays a role in regulating body weight may be a key to understanding how hibernating bears can remain inactive for so long and not experience bone loss, according to a research team led by a ...

Medical research created May 17, 2012 | popularity not rated yet | comments 0


Building a drug delivery platform to regenerate heart tissue

(Medical Xpress) -- While current heart-attack treatments mainly try to preserve healthy heart tissue, scientists have been finding compounds that can stimulate growth of new tissue – either by getting heart muscle ...

Internet porn bad for adolescent health

Emerging evidence indicates that internet pornography is strongly associated with risky sexual behavior among adolescents, according a review from UNSW's Kirby Institute.

Woman with flesh-eating disease takes own breaths

(AP) -- The father of a young Georgia woman fighting a flesh-eating bacteria says his daughter is now breathing on her own.

Research holds out hope for stroke patients

(Medical Xpress) -- People with a curious condition that causes them to apply make-up on only one side of their face, or ignore food on half of their plate, are playing a new role in understanding stroke recovery.

Folic acid may reduce some childhood cancers

Folic acid fortification of foods may reduce the incidence of the most common type of kidney cancer and a type of brain tumors in children, finds a new study by Kimberly J. Johnson, PhD, assistant professor at the Brown School ...

Blocking DNA: HDAC inhibitor targets triple negative breast cancer

The histone de-acetylase (HDAC) inhibitor panobinostat is able to target and destroy triple negative breast cancer, reveals a new study published in BioMed Central's open access journal Breast Cancer Research. Researchers from T ...